MyoTherix
2013
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$8.43M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of innovative therapeutics intended to be used for the treatment of muscle disorders. The company's therapeutics utilize an innovative and novel approach to target both cardiac and skeletal muscle weakness, enabling targeted patients to avail disease-modifying drugs and therapies.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 29540 Kohoutek Way
- Union City, CA 94587
- United States
+1 (857) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore MyoTherix’s full profile, request a free trial.
MyoTherix Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 27-Feb-2017 | $8.43M | 00.00 | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 08-Jul-2015 | 000 | 000 | 000 | Completed | Generating Revenue |
MyoTherix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.00 |
MyoTherix Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| CureDuchenne Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
MyoTherix Executive Team (4)
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »MyoTherix Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| John Kincaid | MyoTherix | Co-Founder, President & Board Member | 000 0000 | |
| Mark De Souza Ph.D | MyoTherix | Co-Founder, Chief Operating Officer & Board Member | 000 0000 | |
| Michael Kelly Ph.D | MyoTherix | Chief Executive Officer, Director & Co-Founder | 000 0000 |
1 Former Board Member
You’re viewing 3 of 4 board members. Get the full list »